The impact of pulmonary artery to ascending aorta diameter ratio progression on the prognosis of NSCLC patients treated with immune checkpoint inhibitorsBingxin Gong, Bo Liang, Weiwei Liu et al.|Frontiers in Immunology|2024Cited by 5